We are a global team of the best and brighest problem solvers working to accelerate oncology innovations to prevent and cure cancer. Each member of our team is
🚀 “This venture studio strengthens our ability to bring Moffitt’s expertise & innovations to cancer patients around the world.” – Patrick Hwu, M.D., President & CEO @MoffittNews
With @AccelerOnc Studio, we’re entering a new era where AI & digital tech transform cancer care.
🚀 Introducing AccelerOnc Studio—the nation’s first venture studio solely dedicated to cancer innovation, founded by @MoffittNews Cancer Center.
Learn more: https://t.co/nmrtjwFQWK
#AccelerOnc#InnovationToImpact
Today we’re celebrating the launch of @AccelerOnc, the first U.S. venture studio focused solely on oncology innovation and founded by Moffitt. By merging data, expertise and urgency, we’re driving bold ideas forward to prevent and cure cancer.
#InnovationToImpact
More than a venture builder, AccelerOnc is a strategic enabler of Moffitt’s mission to prevent & cure cancer—creating early-stage companies rooted in real-world patient & clinical needs.
Together, we’re shaping the future of oncology.
#AccelerOnc#InnovationToImpact#CancerCare
Cancer is becoming more complex. Care is becoming more data-driven
@AccelerOnc provides a bold new way to bridge the gap between discovery & impact—turning world-class research & clinical expertise into companies that deliver real solutions for patients
https://t.co/nmrtjwFj7c
Our focus spans the next frontier of cancer care:
🔹 Digital Health
🔹 Artificial Intelligence
🔹 Data-driven platforms
Each designed to accelerate the path from innovation → impact.